22NW, LP
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), 22NW, LP reported 16 stock positions worth $145.9 million. Its top holding was Foster (lb) Class A (FSTR) at 20.4% of the portfolio, followed by Nektar Therapeutics (NKTR, 13.9%) and Lifecore Biomedical (LFCR, 12.9%). Compared with Q4 2025, it opened 1 new position, sold out of 5, added to 3 and reduced 4. The biggest buy was a new position in Fox Factory (FOXF) and the biggest sale an exit from Anebulo Pharmaceuticals (ANEB).
- Most Recent 13F
- Q2 2026
- Location
- SEATTLE, WA
- CIK
- 0001694297
- Portfolio Value
- $145.9M (Q1 2026)
- SEC Filing
- 0001214659-26-006481 ↗ filed May 15, 2026
Holdings Value
Holdings 16 stocks · $145.9M
| FSTR Foster (lb) Co. Class A | 20.41% | 1,067,186 | $29.8M | Reduce -10.4% |
| NKTR Nektar Therapeutics | 13.86% | 281,115 | $20.2M | Reduce -15.1% |
| LFCR Lifecore Biomedical Inc. | 12.93% | 1,254 | $18.9M | No change |
| NSP Insperity Inc. | 9.14% | 493,000 | $13.3M | Add +411.9% |
| MLYS Mineralys Therapeutics Inc. | 8.25% | 444,325 | $12.0M | Add +24.0% |
| SRI Stoneridge Inc. | 8.17% | 2,466,975 | $11.9M | Add +12.5% |
| FOXF Fox Factory Holding Corp. | 7.65% | 678,165 | $11.2M | New |
| CULP Culp Inc. | 3.49% | 1,859,061 | $5.1M | No change |
| CMT Core Molding Technologies Inc. | 3.42% | 222,738 | $5.0M | No change |
| RGNX Regenxbio Inc. | 2.83% | 492,759 | $4.1M | Reduce -46.6% |
| UFI Unifi Inc. | 2.09% | 852,455 | $3.0M | No change |
| TISI Team Inc. | 1.86% | 170,187 | $2.7M | No change |
| RZLT Rezolute Inc. | 1.72% | 820,653 | $2.5M | No change |
| FARM Farmer Bros Co. | 1.70% | 1,955,526 | $2.5M | No change |
| ELDN Eledon Pharmaceuticals Inc. | 1.34% | 636,364 | $2.0M | No change |
| PFX Phenixfin Corp. | 1.15% | 43,115 | $1.7M | Reduce -63.4% |
Portfolio Sells Q4 2025 → Q1 2026
| ANEB Anebulo Pharmaceuticals Inc. | Sold out | 0.00% | −35.68 |
| MEC Mayville Engineering Co. Inc. | Sold out | 0.00% | −3.26 |
| RGNX Regenxbio Inc. | Reduce -46.6% | 2.83% | −2.77 |
| MGTX Meiragtx Holdings PLC | Sold out | 0.00% | −1.96 |
| PFX Phenixfin Corp. | Reduce -63.4% | 1.15% | −1.04 |
| SSKN Strata Skin Sciences Inc. | Sold out | 0.00% | −0.28 |
| PMDI Psychemedics Corp. | Sold out | 0.00% | −0.19 |
| FSTR Foster (lb) Co. Class A | Reduce -10.4% | 20.41% | +6.90 |
| NKTR Nektar Therapeutics | Reduce -15.1% | 13.86% | +7.97 |
Portfolio Buys Q4 2025 → Q1 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $104.7M | NSP, NKTR, SRI, FOXF, CMT |
| Q1 2026 | 16 | $145.9M | FSTR, NKTR, LFCR, NSP, MLYS |
| Q4 2025 | 20 | $237.6M | ANEB, FSTR, LFCR, NKTR, RGNX |
| Q3 2025 | 21 | $212.3M | ANEB, FSTR, LFCR, NKTR, SRI |
| Q2 2025 | 21 | $158.8M | FSTR, LFCR, ANEB, SRI, DHX |
| Q1 2025 | 20 | $149.1M | LFCR, FSTR, ANEB, STRL, CULP |
| Q4 2024 | 16 | $158.5M | FSTR, LFCR, ANEB, STRL, BBSI |
| Q3 2024 | 13 | $119.3M | FSTR, LFCR, STRL, CULP, ANEB |
| Q2 2024 | 13 | $117.2M | FSTR, LFCR, ANEB, STRL, BBSI |
| Q1 2024 | 13 | $116.1M | FSTR, ANEB, STRL, LFCR, BBSI |